Tackling Non-communicable Diseases with Innovative Approaches
Over the past 30 years, much progress has been made to further understand the human body. However, approximately 14,000 diseases continue to cause suffering in every corner of the world [International Classification of Diseases, ICD-10], most of which lack critical funding or effective therapies. For the vast majority of patients globally, inadequate healthcare access, treatment, and medication are disturbingly common. 71% of deaths worldwide are from chronic, non-communicable diseases. Even though communicable diseases cause fewer deaths, they receive more public and private funding than non-communicable diseases.
Non-communicable diseases can be serious, protracted, and progressive, and nearly half of them manifest during childhood. Mortality from NCD’s is high, with 85% of early deaths occurring in low- and middle-income countries. NCD’s threaten progress towards the United Nation’s Agenda for Sustainable Development Goal #3: Good Health and Well-Being, which strives for a 33% reduction of premature NCD deaths by 2030.
The hurdle remains that many non-communicable diseases fall under the radar of broad public awareness. They usually do not receive necessary attention by for-profit pharmaceutical companies. Therefore, it remains the purview of ILSC and other NGO’s to tackle these persistent maladies to alleviate suffering and premature deaths from underfunded NCD’s.